SCHEMBL5798505

SCHEMBL5798505

CCc1ccccc1N1CCC(C(=O)O)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.58
CASP7 P55210 1/20 0.58
NOTUM Q6P988 5/20 0.56
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KDM4E B2RXH2 2/20 0.49
CYP2C19 P33261 1/20 0.49
POLB P06746 2/20 0.47
APAF1 O14727 1/20 0.47
NSD2 O96028 1/20 0.47
MAPT P10636 1/20 0.47
THRB P10828 1/20 0.47
CASP3 P42574 1/20 0.47
RECQL P46063 1/20 0.47
GALK1 P51570 1/20 0.47
HKDC1 Q2TB90 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27678285 0.87 MEN1 (0.49) CASP1CASP7NOTUMKMT2AMEN1
SCHEMBL3436316 0.82 TSHR (0.58) NOTUMKDM4ECYP2C19MAPTALDH1A1
SCHEMBL5800932 0.81 NOTUM (0.81) NOTUMKMT2AKDM4ECYP2C19POLB
SCHEMBL5798551 0.79 NOTUM (0.58) NOTUMKMT2AL3MBTL1KDM4ECYP2C19
SCHEMBL2559578 0.79 KMT2A (0.60) NOTUMKMT2AMEN1L3MBTL1KDM4E
SCHEMBL5800615 0.79 NOTUM (0.82) NOTUMKMT2AMEN1KDM4ECYP2C19
SCHEMBL5800091 0.79 NOTUM (0.58) NOTUMKMT2AL3MBTL1KDM4ECYP2C19
SCHEMBL10424519 0.78 HTR1A (0.59) KMT2AL3MBTL1KDM4EALDH1A1RAB9A
SCHEMBL5802379 0.78 ALOX15 (0.60) NOTUMKMT2AL3MBTL1KDM4ECYP2C19
SCHEMBL30332339 0.78 GAA (0.52) CASP1CASP7NOTUMKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006058338-A2 4 - PIPERIDINECARBOXAMIDE DERIVATIVES AS MODULATORS OF VANILLOID VR1 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2006-06-01 WO claimed
US-20060116368-A1 4-Piperidinecarboxamide modulators of vanilloid VR1 receptor JANSSEN PHARMACEUTICA N.V. (BE) 2006-06-01 US claimed
US-20060116368-A1 4-Piperidinecarboxamide modulators of vanilloid VR1 receptor JANSSEN PHARMACEUTICA N.V. (BE) 2006-06-01 US disclosed
WO-2006058338-A2 4 - PIPERIDINECARBOXAMIDE DERIVATIVES AS MODULATORS OF VANILLOID VR1 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2006-06-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060116368-A1 4-Piperidinecarboxamide modulators of vanilloid VR1 receptor VDAC1, TRPV1, HVCN1 CASP1 856/4885CASP7 2996/4885NOTUM 3548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.